Alembic Pharma gets EIR from USFDA for facility at Panelav

05 Apr 2019 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA) for the inspection carried out by them at the company’s Formulation Facility at Panelav during the period from October 22, 2018 to October 25, 2018.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

846.75 0.60 (0.07%)
17-Dec-2025 11:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.90
Dr. Reddys Lab 1278.90
Cipla 1492.85
Zydus Lifesciences 917.95
Lupin 2115.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×